H3 Histamine Receptor-Mediated Activation of Protein Kinase Cα Inhibits the Growth of Cholangiocarcinoma In vitro and In vivo

被引:52
|
作者
Francis, Heather [1 ,4 ]
Onori, Paolo [7 ]
Gaudio, Eugenio [5 ]
Franchitto, Antonio [5 ]
DeMorrow, Sharon [1 ,3 ]
Venter, Julie [1 ,3 ]
Kopriva, Shelley [2 ]
Carpino, Guido [6 ]
Mancinelli, Romina [3 ,5 ,7 ]
White, Mellanie [1 ,3 ]
Meng, Fanyin [1 ,4 ]
Vetuschi, Antonella [7 ]
Sferra, Roberta [7 ]
Alpini, Gianfranco [1 ,2 ,3 ]
机构
[1] Texas A&M Hlth Sci Ctr, Coll Med, Scott & White Digest Dis Res Ctr, Temple, TX 76504 USA
[2] Texas A&M Hlth Sci Ctr, Coll Med, Cent Texas Vet Hlth Care Syst, Res, Temple, TX 76504 USA
[3] Texas A&M Hlth Sci Ctr, Coll Med, Div Gastroenterol, Temple, TX 76504 USA
[4] Scott & White Mem Hosp & Clin, Res & Educ, Temple, TX USA
[5] Univ Roma La Sapienza, Rome, Italy
[6] Univ Rome Foro Italico, Dept Hlth Sci, Rome, Italy
[7] State Univ Aquila, Laquila, Italy
关键词
DOWN-REGULATION; H4; RECEPTORS; STIMULATION; VEGF; INVOLVEMENT; EXPRESSION; CLONING; TARGET; CELLS; RATS;
D O I
10.1158/1541-7786.MCR-09-0261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Histamine regulates functions via four receptors (HRH1, HRH2, HRH3, and HRH4). The D-myo-inositol 1,4,5-trisphosphate (IP3)/Ca2+/protein kinase C (PKC)/mitogen-activated protein kinase pathway regulates cholangiocarcinoma growth. We evaluated the role of HRH3 in the regulation of cholangiocarcinoma growth. Expression of HRH3 in intrahepatic and extrahepatic cell lines, normal cholangiocytes, and human tissue arrays was measured. In Mz-ChA-1 cells stimulated with (R)-(alpha)-(-)-methylhistamine dihydrobromide (RAMH), we measured (a) cell growth, (b) IP3 and cyclic AMP levels, and (c) phosphorylation of PKC and mitogen-activated protein kinase isoforms. Localization of PKC alpha was visualized by immunofluorescence in cell smears and immunoblotting for PKC alpha in cytosol and membrane fractions. Following knockdown of PKC alpha, Mz-ChA-1 cells were stimulated with RAMH before evaluating cell growth and extracellular signal-regulated kinase (ERK)-1/2 phosphorylation. In vivo experiments were done in BALB/c nude mice. Mice were treated with saline or RAMH for 44 days and tumor volume was measured. Tumors were excised and evaluated for proliferation, apoptosis, and expression of PKC alpha, vascular endothelial growth factor (VEGF)-A, VEGF-C, VEGF receptor 2, and VEGF receptor 3. HRH3 expression was found in all cells. RAMH inhibited the growth of cholangiocarcinoma cells. RAMH increased IP3 levels and PKC alpha phosphorylation and decreased ERK1/2 phosphorylation. RAMH induced a shift in the localization of PKC alpha expression from the cytosolic domain into the membrane region of Mz-ChA-1 cells. Silencing of PKC alpha prevented RAMH inhibition of Mz-ChA-1 cell growth and ablated RAMH effects on ERK1/2 phosphorylation. In vivo, RAMH decreased tumor growth and expression of VEGF and its receptors; PKC alpha expression was increased. RAMH inhibits cholangiocarcinoma growth by PKC alpha-dependent ERK1/2 dephosphorylation. Modulation of PKC alpha by histamine receptors may be important in regulating cholangiocarcinoma growth. (Mol Cancer Res 2009;7(10):1704-13)
引用
收藏
页码:1704 / 1713
页数:10
相关论文
共 50 条
  • [1] Histamine H3 receptor-mediated inhibition of excitatory synaptic transmission in the rat dentate gyrus in vivo
    Chang, M
    Saito, H
    Abe, K
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1998, 77 (03): : 251 - 255
  • [2] Radiosynthesis of a Histamine H3 receptor antagonist:: In vitro and in vivo evaluation
    Airaksinen, Ann J.
    Jablonowski, J. A.
    van der Mey, M.
    Barbier, A. J.
    Klok, R. P.
    Verbeek, J.
    Schuit, R. C.
    Herscheid, J. D. M.
    Lammertsma, A. A.
    Carruthers, B. I.
    Leysen, J. E.
    Windhorst, A. D.
    [J]. NEUROIMAGE, 2006, 31 : T46 - T46
  • [3] Histamine H3 receptor-mediated inhibition of noradrenaline release in the human brain
    Schlicker, E
    Werthwein, S
    Zentner, J
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1999, 13 (01) : 120 - 122
  • [4] Histamine H3 receptor-mediated inhibition of sympathetically evoked mydriasis in rats
    Yu, YX
    Kawarai, M
    Koss, MC
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 419 (01) : 55 - 59
  • [5] Histamine H3 Receptor-Mediated Signaling Protects Mice from Cerebral Malaria
    Beghdadi, Walid
    Porcherie, Adeline
    Schneider, Bradley S.
    Morisset, Severine
    Dubayle, David
    Peronet, Roger
    Dy, Michel
    Louis, Jacques
    Arrang, Jean-Michel
    Mecheri, Salaheddine
    [J]. PLOS ONE, 2009, 4 (06):
  • [6] A NOVEL PATHWAY FOR RECEPTOR-MEDIATED ACTIVATION OF PROTEIN-KINASE-C
    MCPHAIL, LC
    AGWU, DE
    COUSART, SL
    MCCALL, CE
    [J]. JOURNAL OF CELL BIOLOGY, 1986, 103 (05): : A343 - A343
  • [7] Novel partial agonists for the histamine H3 receptor with high in vitro and in vivo activity
    Sasse, A
    Stark, H
    Reidemeister, S
    Hüls, A
    Elz, S
    Ligneau, X
    Ganellin, CR
    Schwartz, JC
    Schunack, W
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (20) : 4269 - 4274
  • [8] Modulation of H2 histamine receptor-mediated cAMP generation and granulocytic differentiation by extracellular nucleotides via activation of protein kinase C
    Suh, BC
    Lee, H
    Lee, IS
    Kim, KT
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2001, 69 (01) : 169 - 176
  • [9] Histamine is required for H3 receptor-mediated alcohol reward inhibition, but not for alcohol consumption or stimulation
    Vanhanen, J.
    Nuutinen, S.
    Lintunen, M.
    Maki, T.
    Ramo, J.
    Karlstedt, K.
    Panula, P.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (01) : 177 - 187
  • [10] HISTAMINE H3 RECEPTOR-MEDIATED INHIBITION OF GASTRIC-ACID SECRETION IN CONSCIOUS DOGS
    SOLDANI, G
    MENGOZZI, G
    INTORRE, L
    DEGIORGI, G
    CORUZZI, G
    BERTACCINI, G
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1993, 347 (01) : 61 - 65